Dr Reddys: Trading Window Closed for Q2 FY27 Results

Dr. Reddy's Laboratories Ltd. announced that its Board of Directors will convene on Friday, October 23, 2026, to review and approve the unaudited standalone and consolidated financial results for the quarter ending September 30, 2026. In compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the company's securities will be closed for all designated persons. This closure period will commence from September 24, 2026, and conclude on October 25, 2026, inclusive of both dates, to prevent any potential insider trading activities ahead of the financial results announcement.